None listed
Conditions
Brief summary
The aim of this study is to collect information treatment and patient choice in early-stage breast cancer patients. Who is it for? You may be eligible to join this study if you are male or female, aged older than 18 years, and have early-stage breast cancer. Study details At the start of the study, all participants will be asked a series of questionnaires on demographics, perceptions about cancer treatment, and beliefs about medicine; this will be conducted by phone, online, or face-to- face. Afterwards, patient records will be reviewed for breast cancer events, and all participants will be followed up with a brief survey on treatment compliance every 3 months for the first 2 years, then every 6 months up to 5 years. It is hoped that this study will reveal how patient beliefs influence their choice of treatment, and hence allow better psychosocial understanding of breast cancer patients.
Interventions
Patients with Early Breast Cancer who have been recommended for further treatment, either chemotherapy, endocrine therapy or combination, will be asked to participate. Patients will be asked whether they intend to comply with the recommendation of their treating clinician. Patients will also be asked to complete a range of questionnaires at baseline as well as provide demographic information (age, ethnicity, education level, employment status). Questionnaires include:
Beliefs about medicine que
Patients with Early Breast Cancer who have been recommended for further treatment, either chemotherapy, endocrine therapy or combination, will be asked to participate. Patients will be asked whether they intend to comply with the recommendation of their treating clinician. Patients will also be asked to complete a range of questionnaires at baseline as well as provide demographic information (age, ethnicity, education level, employment status). Questionnaires include: Beliefs about medicine questionnaire (BMQ - General, BMQ - endocrine specific, BMQ-chemotherapy specific as applicable), Hospital Anxiety and Depression Scale (HADS), use of Complementary and Alternative Medicines (CAMs), fear of treatment, negative experiences (self and friends/family). Patients will then be followed for 5 years with a brief, 5-question survey (Medical Adherence Report Scale MARS-5 - at 3 monthly intervals for 2 years, then 6 monthly up to 5 years) to assess self-reported compliance to ongoing treatment. Patient records will be reviewed for clinician-reported compliance and and breast cancer recurrence events
Sponsors
Breast Cancer Research Centre - WA
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
a) Written consent to participate. b) Female or male aged over 18 years with early-stage breast cancer (stages 0 to III). Patients with unilateral or bilateral breast cancer are eligible. c) Recommended for systemic neoadjuvant (N) and/or adjuvant (A) treatment by member of PBCI. d) Planned to continue their care with a clinician at PBCI following initiation of adjuvant systemic treatment. e) Patient regards themselves as fluent in English f) Patients with an earlier history of breast cancer are eligible, as long as they are considered disease-free from the first BC diagnosis.
Exclusion criteria
a) Prior history of another malignancy for which the patient is not considered cured b) Systemic treatment recommendations and administration is outside the PBCI c) Medical indication is identified during the period of pre-systemic treatment commencement which alters the MO’s systemic treatment recommendation on a risk vs. benefit balance leading to a recommendation to not receive systemic treatment
Outcome results
None listed